4th Bone Tumor Limb Reconstruction and 3D Printing Technology Clinical Translational Application Workshop
2018-12-09
Kangli Medical Group participates in the 4th Bone Tumor Limb Reconstruction and 3D Printing Technology Clinical Translational Application Workshop at the Ninth People’s Hospital, Affiliated with Shanghai Jiao Tong University School of Medicine.
On December 8, 2018, the International Summit Forum on the Application, Transformation, and Personalized Medicine of Cutting-edge Medical Technologies, and the 4th Bone Tumor Limb Reconstruction and 3D Printing Technology Clinical Translational Application National Continuing Education Workshop, was successfully held at the 3D Printing Innovation Research Center of Shanghai Jiao Tong University School of Medicine. The workshop was organized by the National Alliance of 3D Printing Innovation Research Centers of Shanghai Jiao Tong University School of Medicine, the Clinical Translational Research and Development Center of 3D Printing Technology at the Ninth People’s Hospital, Affiliated with Shanghai Jiao Tong University School of Medicine, the Department of Orthopedics at the Ninth People’s Hospital, Affiliated with Shanghai Jiao Tong University School of Medicine, and the Ministry of Education Engineering Research Center for Clinical Transformation of Digital Medicine. It was co-sponsored by Shanghai Shengshi Medical Instrument Technology Co., Ltd.
Firstly, a speech was delivered by Academician Dai Kerong, who introduced the significant progress made in the clinical use of 3D printing in orthopedic surgery and the rapid dissemination of personalized treatment concepts. Under the leadership of Academician Dai Kerong, the 3D Printing Innovation Research Center of Shanghai Jiao Tong University School of Medicine has established a technical system that integrates medical image processing, biomechanical analysis, personalized medical device design, 3D printing fabrication, and clinical application.
Next, Professor Hao Yongqiang, Professor Shao Zengwu, Professor Wang Xudong, Professor Qu Xingzhou, Professor Han Dong, Professor Ai Songtao, Dr. Cai Zongyuan, and Dr. Jiang Wenbo shared their expertise in medical 3D printing technology, including topics such as imaging, biomechanics, materials, as well as collaborative case studies in various disciplines such as orthopedics, oral medicine, plastic surgery, tissue engineering, and more.
Professor Hao Yongqiang
Topic: Personalized Medicine and 3D Printing
Professor Shao Zengwu
Topic: Application of 3D Printing Technology in the Field of Pelvic Tumors
Professor Wang Xudong
Topic: Application and Research Progress of 3D Printing in the Field of Oral and Maxillofacial Surgery
Professor Qu Xingzhou
Topic: Application of 3D Printing in the Field of Oral and Cranio-Maxillofacial Tumors
Professor Han Dong
Topic: Advances in the Application of 3D Printing Technology in Plastic Surgery
Professor Ai Songtao
Topic: Imaging Issues in Medical Applications of 3D Printing
Dr. Cai Zongyuan
Topic: Functional Evaluation of Customized Implantable Devices in 3D Printing
Dr. Jiang Wenbo
Topic: Expert Consensus Discussion on the Medical-Engineering Interaction in 3D Printing Medical Applications
Simultaneously, a live remote consultation was conducted with the 3D Printing Sub-center of the People’s Hospital in Guigang City, Guangxi. Academician Dai Kerong, Professor Hao Yongqiang, and other experts conducted on-site analysis of the consultation cases and provided guiding recommendations for surgical plans.
The attending participants greatly cherished this opportunity and actively raised questions to the experts regarding the course content. They sought advice on resolving difficult problems encountered in their practical work. The lecturers on stage addressed each of the challenging questions raised and provided detailed explanations and solutions.
Shanghai Shengshi Medical Technology Co., Ltd. was established in 1998 and its technological foundation comes from the team of Professor Dai Kerong in the Department of Orthopedics at the Ninth People’s Hospital in Shanghai. It is a specialized company engaged in the research, development, production, and sales of customized artificial joints (the only one approved by the National Medical Products Administration) and orthopedic products such as shape memory alloys. It was one of the earliest companies in China to conduct research and application of 3D printed models and implants. In April 2016, Suzhou Kangli Orthopedic Instruments Co., Ltd. acquired Shanghai Shengshi Medical Technology Co., Ltd. as a wholly-owned subsidiary.
Suzhou Kangli Medical Group is a specialized enterprise that integrates research, design, manufacturing, and sales of Class II and Class III orthopedic implants and related surgical instruments. The group consists of several subsidiaries, including Suzhou Kangli Orthopedic Instruments Co., Ltd., founded in 1994, Hunan Hengtian Biotechnology, acquired in 2014, Shanghai Shengshi Medical Technology, acquired in 2016, and Suzhou Yunzhi Medical Technology, established in 2016. Since its establishment, the group has developed a diversified layout in the medical field, forming eight major product lines in trauma, spine, joints, cranio-maxillofacial, hand and foot surgery, thoracic surgery, pediatric orthopedics, and bovine bone-bioimplant fusion. The group has obtained various certifications and qualifications, including GMP production quality standards, FDA certification in the United States, CE certification in the European Union, ISO 9001 quality management system certification, and ISO 13485 medical device quality management system certification.